Amalgamated Bank Has $1.58 Million Holdings in Envista Holdings Co. (NYSE:NVST)

Amalgamated Bank decreased its holdings in shares of Envista Holdings Co. (NYSE:NVST) by 18.1% in the 3rd quarter, HoldingsChannel.com reports. The firm owned 79,857 shares of the company’s stock after selling 17,607 shares during the period. Amalgamated Bank’s holdings in Envista were worth $1,578,000 as of its most recent SEC filing.

Several other large investors have also added to or reduced their stakes in the business. Ariel Investments LLC boosted its holdings in Envista by 11.0% during the second quarter. Ariel Investments LLC now owns 9,871,152 shares of the company’s stock worth $164,157,000 after purchasing an additional 978,952 shares during the last quarter. Nuance Investments LLC boosted its holdings in Envista by 47.2% during the second quarter. Nuance Investments LLC now owns 7,038,313 shares of the company’s stock worth $117,048,000 after purchasing an additional 2,256,993 shares during the last quarter. American Century Companies Inc. boosted its holdings in Envista by 15.4% during the second quarter. American Century Companies Inc. now owns 6,726,651 shares of the company’s stock worth $111,864,000 after purchasing an additional 897,141 shares during the last quarter. Jupiter Asset Management Ltd. acquired a new position in Envista during the second quarter worth $69,534,000. Finally, Van Lanschot Kempen Investment Management N.V. boosted its holdings in Envista by 32.9% during the second quarter. Van Lanschot Kempen Investment Management N.V. now owns 2,936,916 shares of the company’s stock worth $48,841,000 after purchasing an additional 727,406 shares during the last quarter.

Wall Street Analyst Weigh In

NVST has been the subject of several recent research reports. JPMorgan Chase & Co. cut shares of Envista from an “overweight” rating to a “neutral” rating and reduced their target price for the stock from $23.00 to $16.00 in a report on Thursday, August 8th. Robert W. Baird upped their price target on shares of Envista from $17.00 to $22.00 and gave the stock a “neutral” rating in a research report on Thursday, October 31st. Stifel Nicolaus upped their price target on shares of Envista from $18.00 to $21.00 and gave the stock a “buy” rating in a research report on Wednesday, October 23rd. Piper Sandler upped their price target on shares of Envista from $16.00 to $17.00 and gave the stock a “neutral” rating in a research report on Thursday, October 31st. Finally, Wells Fargo & Company started coverage on shares of Envista in a research report on Tuesday, October 8th. They set an “equal weight” rating and a $20.00 price target on the stock. One equities research analyst has rated the stock with a sell rating, eleven have issued a hold rating and three have given a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $20.71.

Envista Price Performance

NYSE:NVST opened at $20.52 on Wednesday. Envista Holdings Co. has a 52 week low of $15.15 and a 52 week high of $25.64. The firm has a market cap of $3.53 billion, a price-to-earnings ratio of -2.67, a P/E/G ratio of 2.87 and a beta of 1.30. The firm’s 50-day simple moving average is $18.97 and its 200 day simple moving average is $18.10. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.77 and a current ratio of 2.08.

Envista (NYSE:NVST) last released its quarterly earnings results on Wednesday, October 30th. The company reported $0.12 EPS for the quarter, topping analysts’ consensus estimates of $0.09 by $0.03. Envista had a negative net margin of 53.42% and a positive return on equity of 3.76%. The business had revenue of $601.00 million for the quarter, compared to analyst estimates of $590.34 million. During the same period last year, the firm earned $0.43 earnings per share. Envista’s revenue for the quarter was down 4.8% compared to the same quarter last year. As a group, sell-side analysts predict that Envista Holdings Co. will post 0.71 earnings per share for the current year.

About Envista

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.